BMO Capital Downgrades St. Jude Medical (STJ) to Market Perform
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Price: $80.82 --0%
Rating Summary:
3 Buy, 21 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
3 Buy, 21 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
BMO Capital downgraded St. Jude Medical (NYSE: STJ) from Outperform to Market Perform with a price target of $81.00 (from $80.00).
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $76.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- Petpal Pet Nutrition Technology (300673:CH) PT Raised to RMB14.60 at Goldman Sachs
- Jefferies Downgrades Calix (CALX) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
